BiotechFrance

To finance the research programs of its vaccine candidates in asthma and food allergy, the company founded in 1993 has raised nearly €40M in the form of convertible bonds (Oceane) since its takeover in 2020. An innovative source of financing for this

BiotechFrance

Founded in late 2025, the Avignon biotech signs a scientific collaboration with Gustave Roussy to select its first vaccine candidate in digestive oncology. A funding round has been launched.If cancer vaccines are not new, their effectiveness remains

BiotechInternational

$625 million! That is the amount Kailera Therapeutics raised in its IPO on an euphoric NASDAQ. An amount that surprised not only thecompany, but also market professionals. Indeed, until a few weeks ago, the Waltham, MA-based company was planning to s

BiotechFrance

After positive phase 2 results in the post-myocardial infarction setting, CellProthera believes it has now assembled the key clinical, regulatory and industrial building blocks to enter phase 3. The company, positioned at the biotech/medtech interfac

BiotechInternational

April was particularly eventful for Immutep, illustrating the high volatility that now characterizes the immuno-oncology sector. The company saw its share price plunge sharply, losing nearly 80% of its value following a recommendation from the indepe

BiotechFrance

Announced in January, the deal became effective at the end of April. The platform designed by PathoQuest is intended to perform viral safety testing and genetic characterization for cell and gene therapies, as well as vaccines. With this French acqui

BiotechInternational

To develop its five cystic fibrosis treatments, Vertex conducted approximately 200 adult and pediatric clinical trials in more than 24 countries and 515 centers, which included 22,000 patients. A status update on the progress of research in this rare

BiotechFrance

Research to treat this neurodegenerative brain disorder has raised hopes but also many disappointments. Historically focused on dopamine receptors, it is increasingly targeting other mechanisms such as alpha-synuclein accumulation or addressing hered

BiotechInternational

The news had all the hallmarks of a hoax or a fake news story spread on social media: an Australian data engineer had supposedly treated and saved his dog, Rosie, with a canine anticancer vaccine designed "in his garage" using ChatGPT and AlphaFold,

BiotechFrance

Among the nine start-ups awarded at the HealthTech 2026 Trophies, Biotech Finances highlights three winners that illustrate the diversity of approaches and technological maturities: Methys Dx, FoxBio and One Biosciences.METHYS DX DRIVES CANCER MONITO

BiotechFrance

Second most common chronic neurological disease in France, affecting about 1% of the population, epilepsy remains a conditionthat is little visible to the general public, as well as to investors. The medical director of the specialized investor Angel

Biotech

Less than six months after its creation, SATT Sayens has joined its capital. The biotech aims to become the "Moderna 2.0 of Crohn's disease and ulcerative colitis" with its first orally administered therapeutic RNAs.Oragen Therapeutics is off to a fl